6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
3D113
23-25
Nov
2026
CPHI India 2026
IICC, Yashobhoomi, Dwarka, Delhi
2N53

Loxim Industries Limited

About Loxim Industries Limited

LOXIM is confidently leveraging its decades of expertise in chemistry as it expands into the pharmaceutical industry. Our commitment to innovation and precision in chemistry enables us to offer a comprehensive range of APIs, Intermediates, and CMO & CDMO capabilities to meet the needs of the global pharmaceutical market. Our top-tier R&D facility can handle complex chemical synthesis, analytical methods development, and testing. LOXIM aims to be a responsible business, adding value through its core competency in chemistry while adhering to its core values.

Certifications

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • CPHI India 2026

    IICC, Yashobhoomi, Dwarka, Delhi
    23 Nov 2026 - 25 Nov 2026
  • Country/Region:
    India
  • Founded:
    1977
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
API Producer
Custom Manufacturing/Custom Synthesis
Intermediates Manufacturer
Contact info

Products from Loxim Industries Limited (6)

  • Empagliflozin

    Product Empagliflozin

    (S)-3-(4-(5-Bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran (Empagliflozin Bromo compound)
  • Apixaban

    Product Apixaban

    CAS No. 1267610-26-3
    1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone

    CAS No. 27143-07-3
    Ethyl-2-chloro-2-(2-(4-methoxyphenyl)hydrazineylidene)acetate 
  • Montelukast

    Product Montelukast

    CAS No. 287930-77-2
    2-[3-(S)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]phenyl-2-propanol

    CAS No.  162515-68-6
    [1-(Mercaptomethyl)cyclopropyl]acetic acid
  • Moxifloxacin

    Product Moxifloxacin

    CAS No. 151213-40-0
    (1S,6S)-2,8-Diazabicyclo[4.3.0]nonane

Loxim Industries Limited Resources (1)